Nattokinase Market Size, Share & Trends Analysis Report By Application (Nutraceuticals, Food Additives, Pharmaceuticals, Others), By Region (North America, Europe, Asia Pacific, Central & South America, Middle East & Africa), And Segment Forecasts, 2024 - 2030

Nattokinase Market Size & Trends

The global nattokinase market size was estimated at USD 32.7 million in 2023 and is expected to grow at a CAGR of 3.1% from 2024 to 2030. Cardiovascular diseases (CVDs) is one of the leading cause of death globally. As per the data published by the World Heart Federation in 2021 approximately 20.5 million people died due to Cardiovascular diseases. This statistic has led to a heightened awareness of cardiovascular health, prompting consumers to seek preventive measures. Nattokinase, an enzyme derived from fermented soybeans, is known for its fibrinolytic properties which help in dissolving blood clots and improving circulation. The increasing consumer awareness about the benefits of nattokinase in maintaining cardiovascular health is a major driver for market growth.

The global shift towards natural and functional supplements is another significant driver of the nattokinase market. Consumers are increasingly becoming cautious of synthetic ingredients and are seeking natural alternatives that offer health benefits without adverse side effects. Nattokinase fits this trend as it is a natural enzyme with proven health benefits. The increasing consumer preference for supplements that support overall health and well-being is another key factor driving the sales of nattokinase market. Moreover, manufacturers in the nattokinase market are continually investing in research and development to innovate and launch new products.

Nattokinase is majorly used in dietary supplements; however, its applications are expanding into other areas such as pharmaceuticals, food additives, and cosmetics. The unique properties of this enzyme make it suitable for various applications, thus broadening its market potential. In the pharmaceutical sector, nattokinase is being researched for its potential in developing novel therapeutic agents for cardiovascular diseases. Its natural origin and proven efficacy make it a key ingredient for drug development. Moreover, the increasing interest in natural health solutions among pharmaceutical companies is likely to drive further research and application of nattokinase.

The food and beverage industry is also incorporating nattokinase into functional foods and beverages. These products are designed to offer additional health benefits beyond basic nutrition. The integration of nattokinase into everyday food products is expected to increase its consumption and market penetration. In the cosmetics industry, nattokinase is being used for its potential anti-aging and skin health benefits. The enzyme's ability to improve circulation and dissolve blood clots can enhance skin health, making it a valuable ingredient in skincare formulations. Furthermore, technological advancements in the production processes of nattokinase are contributing to the market growth. Improved fermentation techniques and bioprocessing technologies have enhanced the yield and purity of nattokinase, making it more cost-effective and efficient to produce.

Application Insights

The nutraceutical application accounted for a revenue share of 45.2% in 2023. With increasing awareness about health and wellness, consumers are proactively seeking natural and effective supplements to maintain their health. Nutraceuticals, which include functional foods and dietary supplements, are perceived as safe and beneficial options. The global trend towards preventive healthcare is a significant factor. Consumers are increasingly focused on preventing diseases rather than treating them. Nutraceuticals containing nattokinase are marketed as preventive measures for cardiovascular health, which is a major concern worldwide, given the high prevalence of heart diseases. Nattokinase is known for its cardiovascular benefits resulting in its increasing use in the production of dietary supplements thus driving the market growth.

Pharmaceutical application is expected to grow at a CAGR of 3.6% from 2024 to 2030. With the rise in chronic diseases, particularly cardiovascular diseases, there is a growing demand for effective treatments. With its fibrinolytic properties, Nattokinase is increasingly incorporated into pharmaceutical formulations to manage conditions like thrombosis, hypertension, and others. Moreover, pharmaceutical companies are investing heavily in research and development to explore the therapeutic potential of nattokinase. These investments are leading to the discovery of new applications and formulations, driving market growth.

Regional Insights

The North American market is driven by a strong trend towards health and wellness. Consumers are increasingly seeking natural health supplements to improve their overall well-being, which boosts the demand for nattokinase. The region has a high prevalence of cardiovascular diseases, with heart disease being a leading cause of death. The need for effective preventive and therapeutic solutions is driving the adoption of nattokinase. As per the data published by American Heart Association, in 2020, approximately 928,741 deaths in the US were attributed to cardiovascular disease (CVD),

U.S. Nattokinase Market Trends

The nattokinase market in U.S. is expected to grow at a CAGR of 3.4% from 2024 to 2030. The U.S. has one of the highest healthcare expenditures globally, allowing consumers to invest in preventive health measures and supplements like nattokinase. Moreover, there is a high level of health awareness among U.S. consumers. They are well-informed about the benefits of natural supplements and are proactive in adopting them. Owing to such factors use of nattokinase in supplements is increasingly used thus driving the market growth.

Asia Pacific Nattokinase Market Trends

The nattokinase market in Asia pacific accounted for a revenue share of over 38.5% in the market. In countries like Japan and China, nattokinase has been traditionally used for centuries. The cultural acceptance and historical usage of nattokinase in these regions contribute significantly to its dominant market share. In addition, there is a growing awareness about the importance of cardiovascular health in the region. As consumers become more health-conscious, the demand for natural and effective health supplements like nattokinase is rising. Moreover, Japan is a major producer of nattokinase, ensuring a steady supply of high-quality products. The presence of established manufacturers and the availability of raw materials at competitive prices bolster the market.

Europe Nattokinase Market Trends

European consumers are becoming increasingly health-conscious and are seeking natural supplements to enhance their health. The growing trend towards preventive healthcare is driving the demand for nattokinase. Additionally, the functional foods market in Europe is expanding, with consumers looking for foods that offer additional health benefits. Nattokinase is being incorporated into functional food products, contributing to market growth.

Key Nattokinase Company Insights         

Manufacturers are actively investing in research and development, launching new products, and leveraging marketing strategies to meet the evolving needs of consumers. As the market continues to grow, it is expected to offer numerous opportunities for innovation and expansion, benefiting both manufacturers and consumers.

Recent Developments

• In May 2021, Gnosis by Lesaffre, a global supplier of vitamin K2, has expanded its capabilities by acquiring NattoPharma, another renowned supplier. Vitamin K2 is an essential nutrient for cardiovascular health and bone health, but it is not present in sufficient quantities in the modern diet. Supplementation is necessary as very few foods, like natto, are naturally high in vitamin K2. The acquisition allows Gnosis to offer the most complete portfolio of solutions, adapted to different market needs and to meet consumer needs.

• In May 2021, Compagnie Des Levures Lesaffre, a French company, completed the acquisition of the remaining 23% stake in NattoPharma ASA, a Norwegian biotechnology company.

Nattokinase Market Report Scope

Global Nattokinase Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the global nattokinase market report based on application and region:

• Application Outlook (Revenue, USD Million, 2018 - 2030)

  • Nutraceuticals

  • Food Additives

  • Pharmaceuticals

  • Others

• Regional Outlook (Revenue, USD Million, 2018 - 2030)

  • North America

    • U.S.

    • Canada

  • Europe

    • UK

    • France

    • Germany

    • Spain

    • Italy

  • Asia Pacific

    • China

    • Japan

    • Australia

    • South Korea

  • Central & South America

  • Middle East & Africa